Catalyst Wire Dossier Catalyst Wire Dossier

KP-001

· Kaken Pharmaceutical
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for KP-001, covering 2025-03-07 to 2025-12-19. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Investigate Efficacy and Safety of KP-001 Compared With Placebo in Patients Aged ≥2 Years With Common VM, Common LM, or KTS/CLOVES Syndrome [Phase 3]

See pricing